China Dasheng Biotechnology Stock Net Income
| CDBTDelisted Stock | USD 0.04 0.00 0.00% |
As of the 2nd of February, China Dasheng shows the Downside Deviation of 43.88, risk adjusted performance of 0.1171, and Mean Deviation of 24.74. China Dasheng Biotec technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Analyzing historical trends in various income statement and balance sheet accounts from China Dasheng's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting China Dasheng's valuation are summarized below:China Dasheng Biotechnology does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. China |
Search Suggestions
| CD | Chaince Digital Holdings | Company |
| CDZIP | Cadiz Depositary Shares | Company |
| CDAZX | Multi Manager Directional Alternative | Mutual Fund |
| CDC | VictoryShares EQ Income | ETF |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, China Dasheng Biotechnology reported net income of 4.64 M. This is 99.64% lower than that of the Financial Services sector and significantly higher than that of the Shell Companies industry. The net income for all United States stocks is 99.19% higher than that of the company.
China Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses China Dasheng's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of China Dasheng could also be used in its relative valuation, which is a method of valuing China Dasheng by comparing valuation metrics of similar companies.China Dasheng is currently under evaluation in net income category among its peers.
China Fundamentals
| Return On Equity | 0.39 | |||
| Return On Asset | 0.2 | |||
| Profit Margin | 0.31 % | |||
| Operating Margin | 0.34 % | |||
| Current Valuation | 8.1 M | |||
| Price To Earning | 0.33 X | |||
| Price To Book | 0.47 X | |||
| Price To Sales | 0.17 X | |||
| Revenue | 16.29 M | |||
| Gross Profit | 7.5 M | |||
| EBITDA | 7.72 M | |||
| Net Income | 4.64 M | |||
| Cash And Equivalents | 10.41 M | |||
| Cash Per Share | 0.35 X | |||
| Total Debt | 1.46 M | |||
| Current Ratio | 6.63 X | |||
| Book Value Per Share | 0.64 X | |||
| Cash Flow From Operations | 4.1 M | |||
| Earnings Per Share | 0.03 X | |||
| Number Of Employees | 689 | |||
| Beta | 1.78 | |||
| Market Capitalization | 3.6 M | |||
| Total Asset | 20.25 M | |||
| Retained Earnings | 14.21 M | |||
| Working Capital | 12.54 M | |||
| Current Asset | 14.77 M | |||
| Current Liabilities | 2.23 M | |||
| Z Score | 1.2 | |||
| Net Asset | 20.25 M |
About China Dasheng Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze China Dasheng Biotechnology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of China Dasheng using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of China Dasheng Biotechnology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in China Pink Sheet
If you are still planning to invest in China Dasheng Biotec check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the China Dasheng's history and understand the potential risks before investing.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |